132 related articles for article (PubMed ID: 19330336)
1. [Favorable response of pulmonary rheumatoid nodule to Rituximab].
Oqueka T; Schultz H; Moosig F
Z Rheumatol; 2009 Jun; 68(4):343-4. PubMed ID: 19330336
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry).
Glace B; Gottenberg JE; Mariette X; Philippe R; Pereira B; Lequerré T; Berthelot JM; Dougados M; Toussirot E; Pham T; Allanore Y; Loeuille D; Euller-Ziegler L; Soubrier M
Ann Rheum Dis; 2012 Aug; 71(8):1429-31. PubMed ID: 22504557
[No Abstract] [Full Text] [Related]
3. [Regression of peripheral and pulmonary rheumatoid nodules under therapy with rituximab].
Braun MG; Wagener P
Z Rheumatol; 2013 Mar; 72(2):166-71. PubMed ID: 23052405
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of rituximab on pulmonary nodulosis occurring or increasing in patients with rheumatoid arthritis during anti-TNF-α therapy.
De Stefano R; Frati E; Nargi F; Menza L
Clin Exp Rheumatol; 2011; 29(4):752-3. PubMed ID: 21906436
[No Abstract] [Full Text] [Related]
5. Complete disappearance of pulmonary rheumatoid nodules after long term rituximab treatment: case report.
Frade-Sosa B; Azuaga AB; Ruiz-Esquide V; Gómez-Puerta JA; Sanmarti R
Rheumatol Int; 2023 Mar; 43(3):533-536. PubMed ID: 36318308
[TBL] [Abstract][Full Text] [Related]
6. Marked improvement of lung rheumatoid nodules after treatment with tocilizumab.
Andres M; Vela P; Romera C
Rheumatology (Oxford); 2012 Jun; 51(6):1132-4. PubMed ID: 22328566
[No Abstract] [Full Text] [Related]
7. A 48-Year-Old South African Woman with Rheumatoid Arthritis and Lung Nodules.
Koslow M; Bennji SM; Griffith-Richards S; Ahmad K; Johnson GB; Ryu JH; Nathan SD; Allwood BW
Chest; 2020 May; 157(5):e151-e155. PubMed ID: 32386648
[TBL] [Abstract][Full Text] [Related]
8. Rituximab as effective treatment in a case of severe subcutaneous nodulosis in rheumatoid arthritis.
Sautner J; Rintelen B; Leeb BF
Rheumatology (Oxford); 2013 Aug; 52(8):1535-7. PubMed ID: 23329684
[No Abstract] [Full Text] [Related]
9. [Recommendations on the use of rituximab for patients with rheumatoid arthritis].
Rubbert-Roth A; Burmester G;
Z Rheumatol; 2008 Nov; 67(7):609-13. PubMed ID: 18830700
[No Abstract] [Full Text] [Related]
10. [Rituximab treatment of rheumatoid arthritis: new evidence].
Nasonov EL
Ter Arkh; 2009; 81(6):82-91. PubMed ID: 19663200
[TBL] [Abstract][Full Text] [Related]
11. Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy.
Venerito V; Lopalco G; Anelli MG; Cacciapaglia F; Iannone F
Rheumatology (Oxford); 2019 Mar; 58(3):440. PubMed ID: 30212893
[No Abstract] [Full Text] [Related]
12. Safety of rituximab in rheumatoid arthritis patients with a history of severe or recurrent bacterial infection: observational study of 30 cases in everyday practice.
Toussirot E; Pertuiset E; Sordet C; Augé B; Wendling D; Pallot-Pradès B; Collet P; Lohse A; Balblanc JC
Joint Bone Spine; 2010 Mar; 77(2):142-5. PubMed ID: 20171921
[TBL] [Abstract][Full Text] [Related]
13. Unusual onset of rheumatoid arthritis with diffuse pulmonary nodulosis: a diagnostic problem.
Laloux L; Chevalier X; Maitre B; Lange F; Chanzy MO; Larget-Piet B; Claudepierre P
J Rheumatol; 1999 Apr; 26(4):920-2. PubMed ID: 10229417
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)).
Emery P; Deodhar A; Rigby WF; Isaacs JD; Combe B; Racewicz AJ; Latinis K; Abud-Mendoza C; Szczepanski LJ; Roschmann RA; Chen A; Armstrong GK; Douglass W; Tyrrell H
Ann Rheum Dis; 2010 Sep; 69(9):1629-35. PubMed ID: 20488885
[TBL] [Abstract][Full Text] [Related]
15. Colchicine therapy for low-dose-methotrexate-induced accelerated nodulosis in a rheumatoid arthritis patient.
Abraham Z; Rozenbaum M; Rosner I
J Dermatol; 1999 Oct; 26(10):691-4. PubMed ID: 10554438
[TBL] [Abstract][Full Text] [Related]
16. Tocilizumab: new drug. Rheumatoid arthritis: another 'mab', no therapeutic advantage.
Prescrire Int; 2009 Oct; 18(103):198-201. PubMed ID: 19882783
[TBL] [Abstract][Full Text] [Related]
17. Treatment with tocilizumab leads to the disappearance of olecranon rheumatoid nodules.
Al Attia HM; Abushawish M
Int J Dermatol; 2012 Feb; 51(2):197-8. PubMed ID: 21913909
[No Abstract] [Full Text] [Related]
18. Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab).
Bruzzese V; Pepe J
Reumatismo; 2009; 61(4):306-8. PubMed ID: 20143007
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of rituximab in patients with rheumatoid arthritis refractory or with contra-indication to anti-tumor necrosis factor-alpha drugs in daily practice: an open label observational study.
Assous N; Gossec L; Dougados M; Kahan A; Allanore Y
Clin Exp Rheumatol; 2007; 25(3):504. PubMed ID: 17631755
[No Abstract] [Full Text] [Related]
20. [How effective is rituximab in rheumatoid arthritis?: lessons learned from clinical practice].
Schmidt WA; Schicke B; Krause A; Wernicke D
Z Rheumatol; 2010 Jun; 69(4):349-55. PubMed ID: 19449016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
